2025年类风湿关节炎临床试验中的影像学:我们处于什么位置?
本文综述了超声和磁共振成像(MRI)在类风湿关节炎临床试验中作为结局测量工具的应用,二者对关节和腱鞘炎症的检测具有真实性、可重复性和敏感性,并具备验证过的评分系统;MRI还能敏感且具区分度地评估结构损伤进展,其他影像技术及人工智能在未来临床试验中具有潜在应用前景。
要点
- 超声和MRI对关节及腱鞘炎症的检测真实、可重复且对变化敏感,并有验证过的评分系统。
- MRI可敏感且具区分度地评估类风湿关节炎结构损伤进展,同样有验证过的结局测量工具。
- 人工智能等其他影像技术在未来临床试验中具有潜在可能性。
核心结论
- 超声和MRI可作为类风湿关节炎临床试验中炎症和结构损伤的结局测量工具,其他影像技术及人工智能具有未来应用可能性。
研究设计与样本
- 综述文章,检索范围与纳入文献原文未报告。
诊断标准与关键数值
- 超声和MRI对关节和腱鞘炎症的检测被证明真实、可重复且对变化敏感,并具有验证过的评分系统。
- MRI可敏感且具区分度地评估类风湿关节炎结构损伤进展,并有验证过的结局测量工具。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Accurate detection and assessment of inflammatory activity is crucial not only for diagnosing patients with rheumatoid arthritis but also for effective monitoring of treatment effect. Ultrasound and magnetic resonance imaging (MRI) have both been shown to be truthful, reproducible, and sensitive to change for inflammation in joints and tendon sheaths and have validated scoring systems, which altogether allow them to be used as outcome measurement instruments in clinical trials. Furthermore, MRI also allows sensitive and discriminative assessment of structural damage progression in RA, also with validated outcome measures. Other relevant imaging techniques, including the use of artificial intelligence, pose interesting possibilities for future clinical trials and will be briefly addressed in this review article.
引用
- Østergaard M, Rolland MAJ, Terslev L, et al. Imaging in clinical trials of rheumatoid arthritis: where are we in 2025? Skeletal Radiol. 2025. PMID: 40762694. doi:10.1007/s00256-025-05004-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。